Hasan Baysal

Simultaneous targeting of <scp>EGFR</scp>,<scp> HER</scp>2, and <scp>HER</scp>4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines

Ines De Pauw, Filip Lardon, Jolien Van den Bossche et al. · Molecular Oncology · 2018 · 48 citations · Full text

Medicine, Oncology, Pharmacology +15

Cetuximab-induced natural killer cell cytotoxicity in head and neck squamous cell carcinoma cell lines: investigation of the role of cetuximab sensitivity and HPV status

Hasan Baysal, Ines De Pauw, Hannah Zaryouh et al. · British Journal of Cancer · 2020 · 41 citations · Full text

Medicine, Oncology, Pharmacology +17

The prognostic impact of the immune signature in head and neck squamous cell carcinoma

Hasan Baysal, Vasiliki Siozopoulou, Hannah Zaryouh et al. · Frontiers in Immunology · 2022 · 20 citations · Full text

Medicine, Immunology, Oncology +17

The Role of Akt in Acquired Cetuximab Resistant Head and Neck Squamous Cell Carcinoma: An In Vitro Study on a Novel Combination Strategy

Hannah Zaryouh, Ines De Pauw, Hasan Baysal et al. · Frontiers in Oncology · 2021 · 19 citations · Full text

Medicine, Oncology, Pharmacology +17

Dual Targeting of Epidermal Growth Factor Receptor and HER3 by MEHD7945A as Monotherapy or in Combination with Cisplatin Partially Overcomes Cetuximab Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines

Ines De Pauw, An Wouters, Jolien Van den Bossche et al. · Cancer Biotherapy and Radiopharmaceuticals · 2017 · 18 citations

Medicine, Oncology, Pharmacology +16